Remdesivir is a prodrug of the nucleoside analogue GS-441524 and is under evaluation for treatment of SARS-CoV-2-infected patients.
Pharmacokinetics of remdesivir and GS-441524 in two critically ill patients who recovered from COVID-19
Avataneo, Valeria;D'Avolio, Antonio;
2020-01-01
Abstract
Remdesivir is a prodrug of the nucleoside analogue GS-441524 and is under evaluation for treatment of SARS-CoV-2-infected patients.File in questo prodotto:
File | Dimensione | Formato | |
---|---|---|---|
dkaa239.pdf
Accesso riservato
Tipo di file:
PDF EDITORIALE
Dimensione
247.03 kB
Formato
Adobe PDF
|
247.03 kB | Adobe PDF | Visualizza/Apri Richiedi una copia |
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.